The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...

The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...

We tested the best backcountry ski bindings, including top picks from Salomon, Dynafit, Atomic, and more to help you find the ...

Baby gates sold exclusively on Amazon have been recalled over a potential entrapment risk for children, according to the U.S.

According to the Consumer Product Safety Commission ( CPSC ), around 1,500 UVIPC baby gates sold exclusively on Amazon were ...

IZERVAY dosing approved beyond 12 monthsTOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Ok ...

We remain focused on delivering an exceptional customer experience, ensuring that every stakeholder – from licensees to regulators – receives the support and tools they need to succeed." Metrc’s ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.